484 results on '"Valentino, Leonard A."'
Search Results
2. Race and ethnicity reporting and representation in hemophilia clinical trials
3. A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?
4. Hemophilia gene therapy: first, do no harm
5. Gene Therapy in Hemophilia: Latest Developments
6. Genetics of Hemophilia A and B
7. Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years
8. Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States
9. Joint health and pain in the changing hemophilia treatment landscape.
10. The imperative to prevent joint bleeding in everyone living with hemophilia
11. The intersection of vector biology, gene therapy, and hemophilia
12. Personalising haemophilia management with shared decision making
13. Neuroinflammatory markers in patients with haemophilia and healthy controls: Where are the differences?
14. Increased bone resorption in hemophilia
15. A commentary on “maladaptive lymphangiogenesis” according to Newton’s third law: the law of action and reaction as it applies to joint bleeding
16. Foreword: a special focus on bleeding disorders
17. The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary
18. The National Hemophilia Foundation’s State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders
19. Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community
20. sj-docx-1-taw-10.1177_20420986221146418 – Supplemental material for Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community
21. Defining the Impact of Social Drivers on Health Outcomes for People with Inherited Bleeding Disorders
22. Building the blueprint: Formulating a community‐generated national plan for future research in inherited bleeding disorders
23. Big picture initiatives in bleeding disorders
24. von Willebrand disease (VWD) and BATs: How do they connect and why should I care?
25. Venous access in the management of hemophilia
26. National Hemophilia Foundation Enlists Diverse Patient Voices to Inform a National Research Blueprint for Inherited Bleeding Disorders
27. National Hemophilia Foundation Convenes Diverse Community Voices to Define an Actionable National Research Blueprint for Inherited Bleeding Disorders
28. Bleeding Disorder Data Registry Reveals Racial/Ethnic Disparities That Could Significantly Impact Patient Journey
29. Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders
30. Recent Advances in the Treatment of Hemophilia: A Review
31. Individualizing prophylaxis in hemophilia: a review
32. Return to Sport Activities and Risk of Reinjury Following Primary Anterior Cruciate Ligament Reconstruction.
33. New Drugs in the Pipeline: From Concept to Clinic
34. Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia
35. Discussing investigational AAV gene therapy with hemophilia patients: A guide
36. Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX
37. The role of Rixubis™ in the treatment of hemophilia B
38. Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
39. The role of telemedicine in the delivery of health care in the COVID‐19 pandemic
40. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
41. Results of Genetic Analysis of 11,341 Participants Enrolled in the My Life, Our Future (MLOF) Hemophilia Genotyping Initiative
42. Gangliosides regulate tumor cell adhesion to collagen
43. Prophylaxis in Hemophilia a Patients with Inhibitors
44. Experimental Studies on Hemarthrosis, Synovitis and Arthropathy
45. New Technologies for the Pharmacokinetic Improvement of Coagulation Factor Proteins
46. New Developments in Hemophilic Arthropathy
47. Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Futurehemophilia genotyping initiative in the United States
48. Management of joint bleeding in hemophilia
49. Creating experimental bleeding variability in the mouse model of hemophilia A
50. Prophylaxis for hemophilia A without inhibitors: treatment options and considerations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.